Study of the Familial Cosegregation of Cutaneous Malignant Melanoma and/or Precursor Lesions and the HLA System

Autor: J. P. Cesarini, Jacques Hors, F. Demenais

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d9b5746c9ef9d3ae9a4bc15853f4d59
https://doi.org/10.1159/000412551

Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double blind randomized trial using personal dosimeters

Autor: Jean-François Doré, Ollivaud L, Gianluca Severi, Philippe Autier, Truchetet F, J. P. Cesarini, Rotmensz N, André-Robert Grivegnee, Reis Ac, Chamoun E

Publikováno v: British Journal of Cancer

A previous randomized trial found that sunscreen use could extend intentional sun exposure, thereby possibly increasing the risk of cutaneous melanoma. In a similarly designed trial, we examined the effect of the use of sunscreens having different su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b777897291c105267a220707b02380d9
http://europepmc.org/articles/PMC2363574

Évaluation des risques sanitaires liés à l’utilisation professionnelle des produits bitumineux et de leurs additifs – Résultats de l’expertise collective – Conclusions et recommandations de l’Anses

Autor: C. Fourneau, G. Boulanger, E. Nerriere-Catelinois, M.-L. Cointot, G. Argiles, I. Stücker, M. Lafontaine, J.-P. Cesarini, C.K. Huynh, G. Garçon, B. Appenzeller, H. Schroeder, B. Sutter, D. Bourgeois

Publikováno v: Archives des Maladies Professionnelles et de l'Environnement. 75:514-515

Les bitumes sont des residus de raffinage du petrole. Actuellement, ils constituent l’ingredient principal voire exclusif d’un liant, partie continue assurant la cohesion d’un revetement (routier, d’etancheite de toiture, etc.). La consommati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ab58068896468e053aa475b5613ffcdb
https://doi.org/10.1016/j.admp.2014.07.011

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL

Autor: Nicholas K. Hayward, Hensin Tsao, Mark J. Eliason, Suzanne Egyhazi, Paola Minghetti, Paola Ghiorzo, Alisa M. Goldstein, Julie Lang, Juliette Randerson-Moor, Nicole Basset-Seguin, Clasine van der Drift, D. Timothy Bishop, Nicholas G. Martin, Michel Longy, Guang Yang, Sabina Nasti, Adèle C. Green, Valérie Chaudru, Donato Calista, Sara Gargiulo, Florent Grange, Francisco Cuellar, Linda Whitaker, Joseph Malvehy, Esther Azizi, Richard F. Kefford, David E. Elder, Håkan Olsson, Nelleke A. Gruis, Joan Anton Puig-Butille, David W. Hogg, Margaret A. Tucker, Sushila Mistry, Wilma Bergman, Johan Westerdahl, Christian Ingvar, J. P. Cesarini, Jacqueline Chevrant-Breton, Leny van Mourik, Michela Mantelli, Arupa Ganguly, Jean -Marc Limacher, F. Truchetet, Maria Teresa Landi, Kristin B. Niendorf, Elizabeth A. Holland, Anna Måsbäck, Graham J. Mann, Agnès Chompret, Felix Pavlotsky, Veronica Magnusson, Anton Platz, Joanne F. Aitken, Brigitte Bressac-de Paillerets, Michael Ming, Marie-Françoise Avril, F. Boitier, J. L. Michel, May Chan, R. Cervera, Helen Schmid, Johan Hansson, Rosa M. Martí, Florence Demenais, Celia Badenas, Eitan Friedman, David C. Whiteman, Catherine Dugast, Rainer Tuominen, Lorenza Pastorino, D. Couillet, Emanuel Yakobson, T. Lesimple, Åke Borg, Pascal Joly, Julia A. Newton Bishop, Coby Out-Luiting, Peter A. Kanetsky, Caroline Kanengiesser, Sara Gliori, Diana Linden, Joan Brunet-Vidal, Christine Lasset, William Bruno, Susana Puig, Lisa A. Cannon Albright, Frans A. van Nieuwpoort, Alon Scope, Mitchell S. Stark, Giovanna Bianchi-Scarrà, B. Sassolas, Patricia Van Belle, Elizabeth M. Gillanders, Mark Harland, Jeanet A.C. ter Huurne, Rona M. MacKie, Femke A. de Snoo, Sancy A. Leachman, Jane M. Palmer

Publikováno v: Cancer research. 66(20)

GenoMEL, comprising major familial melanoma research groups from North America, Europe, Asia, and Australia has created the largest familial melanoma sample yet available to characterize mutations in the high-risk melanoma susceptibility genes CDKN2A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4fa0860aa1b2466b099993058f1ff6
https://pubmed.ncbi.nlm.nih.gov/17047042

Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma

Autor: J J, Grob, B, Dreno, P, de la Salmonière, M, Delaunay, D, Cupissol, B, Guillot, P, Souteyrand, B, Sassolas, J P, Cesarini, S, Lionnet, C, Lok, C, Chastang, J J, Bonerandi

Publikováno v: Lancet (London, England). 351(9120)

Owing to the limited efficacy of therapy on melanoma at the stage of distant metastases, a well-tolerated adjuvant therapy is needed for patients with high-risk primary melanoma. Our hypothesis was that an adjuvant treatment with low doses of interfe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::01a3e230a34a886b2f1fa8f8aa0e6e22
https://pubmed.ncbi.nlm.nih.gov/9929057